Practo
Practo delivers 3,500 Cr GMV in FY24; narrows EBITDA losses by 82%
Exclusive: Decoding Practo’s $32 Mn fresh round with 50% lower valuation
Exclusive: Amidst churn at the top, Practo selling Enlightiks in a fire sale
Matrix India announces $300 Mn Fund III; sharp focus on consumer segment
Delhi High Court hammers nationwide ban on online sale of medicines
/entrackr/media/agency_attachments/2024/10/18/XDGqYgwk8PhvKwQWyFWY.png)
/entrackr/media/media_files/2025/08/04/practo-2025-08-04-12-18-08.png)
/entrackr/media/media_files/2025/02/18/R1Hj2r0sf0s4WxWQ6ALS.png)
/entrackr/media/media_files/2025/01/10/DT997OcBLKqrdeyJZ11c.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2023/11/Practo.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2023/06/Practo-feature-image-copy.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2021/01/practo.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2018/01/Practo-image.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2017/10/funding-new-2.jpg)
/entrackr/media/post_attachments/wp-content/uploads/2018/12/medicine-image.jpg)
